87 results
8-K
EX-99.1
AKBA
Akebia Therapeutics Inc.
8 Nov 23
Akebia Therapeutics Reports Third Quarter 2023 Financial Results
7:33am
of shifting payor mix, partially caused by contracting dynamics and a decline in the phosphate binder market. The decline was partially offset by price … the assignment of the Boston lease in May 2023 and a targeted cutback in Auryxia marketing and promotional expense which were offset by some one-time
8-K
EX-99.1
0dq4ua1
25 Aug 23
Akebia Therapeutics Reports Second Quarter 2023 Financial Results
8:14am
8-K
EX-99.1
fkh7v24c bi3cp
8 May 23
Akebia Therapeutics Reports First Quarter 2023 Financial Results and Recent Business Highlights
7:41am
8-K
EX-99.1
84d77rw
9 May 22
Akebia Therapeutics Reports First Quarter 2022 Financial Results and Business Update
4:11pm
8-K
EX-99.1
k0f1j9
1 Mar 22
Akebia Therapeutics Reports Fourth Quarter and Full-Year 2021 Financial Results and Recent Business Highlights
4:04pm
8-K
EX-99.1
hejsu
4 Nov 21
Akebia Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Recent Company Milestones
8:10am